HGH Fragment 176-191

Active Substance: HGH Fragment 176-191

peptideinjectable

Description

HGH Fragment 176-191, also known as hGH Frag 176-191 or AOD-9604, is a modified peptide fragment of human growth hormone (hGH). It's the C-terminal part of the hGH molecule, specifically the amino acids from position 176 to 191. Researchers developed it to mimic the fat-burning effects of growth hormone without causing the unwanted side effects on blood sugar levels or overall growth.


Benefits and Side Effects

Benefits of HGH Fragment 176-191 are primarily related to its potential for fat loss. It's thought to work by stimulating lipolysis (the breakdown of fat) and inhibiting lipogenesis (the formation of fat). It may also improve lipid profiles and glucose control. Some studies suggest it could help with cartilage regeneration and joint health.

Side effects can include headaches, nausea, dizziness, and injection site reactions. Since this is an unregulated substance, the long-term effects are not well-known.


Pros and Cons

Pros 

  • Targeted fat loss: It specifically targets fat cells without the growth-promoting effects of full HGH.

  • Less impact on insulin: It does not appear to negatively affect insulin sensitivity or blood sugar levels, unlike full Hlength HGH.

  • Minimal side effects: It has a generally good safety profile in research settings.

Cons 

  • Lack of human studies: While a modified version (AOD-9604) has been studied, HGH Frag 176-191 itself has not been extensively studied in humans.

  • Unregulated market: It's often sold for "research purposes only" and isn't approved for human consumption, meaning the quality and purity of products can be inconsistent and dangerous.

  • Limited benefits: Unlike full HGH, it does not promote muscle growth or have other anabolic effects.


Dosage and Frequency

Dosage recommendations for HGH Fragment 176-191 are typically based on anecdotal evidence and research protocols, not established medical guidelines. A common dosage is 250-500 mcg per day, administered via subcutaneous injection. It is often split into two daily injections to maintain stable levels. Cycles typically last between 8 and 12 weeks.


Half-Life and Detection Time

  • Half-life: The half-life of HGH Fragment 176-191 is quite short, with estimates ranging from 30 minutes to a few hours. This is why some protocols suggest multiple daily injections.

  • Detection time: Due to its rapid clearance from the body, the detection window is very short. It can be difficult to detect in standard anti-doping tests after about 24 hours.


Hormonal Effects

  • Sterogenic/Progestronic: HGH Fragment 176-191 has no known sterogenic (effects on steroid hormones like testosterone) or progestronic (effects on progesterone) activity. It is not an anabolic-androgenic steroid.

  • Prolactin: There is no evidence that HGH Fragment 176-191 has any effect on prolactin levels.

  • Anabolic-Androgenic Ratio: This ratio is used to measure the anabolic (muscle-building) and androgenic (masculinizing) effects of anabolic-androgenic steroids. Since HGH Fragment 176-191 is a peptide and not a steroid, this ratio does not apply. The ratio is not a numerical value for this substance.

Pharmacological Properties

Half Life

0.2 hours

Active Dose

100%

Detection

0.05 days

Concentration

5000 mcg/vial

Anabolic/Androgenic Profile

Usage Effectiveness

Bulking
Cutting
Strength
Recomposition

Activity Profile

Estrogenic

None

Progestanic

None

Water Retention

None

Aromatization

No

Benefits

✓ Accelerated Fat Loss ✓ Improved Body Composition ✓ Enhanced Joint Health

Dosage Recommendations

Beginner

100-200 mcg/week

Intermediate

200-300 mcg/week

Advanced

300-500 mcg/week

Side Effects

Common

⚠ Headaches ⚠ Nausea ⚠ Injection Site Pain ⚠ Injection Site Swelling

Safety Information

Liver Toxicity

None

Kidney Toxicity

Low

Cardiovascular Risk

Low

Disclaimer: This information is for educational purposes only. Always consult with a qualified healthcare professional before using any compounds.